Literature DB >> 18460741

Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer.

Max Hornstein1, Michèle J Hoffmann, Adrian Alexa, Masanori Yamanaka, Mirko Müller, Volker Jung, Jörg Rahnenführer, Wolfgang A Schulz.   

Abstract

BACKGROUND: Allelic losses on chromosome 8p are common in prostate carcinoma, but it is not known exactly how they contribute to cancer development and progression.
MATERIALS AND METHODS: Expression of 12 genes located across chromosome 8p, including established tumor suppressor candidates (CSMD1, DLC1, NKX3.1), and others from a new microarray-based comparison was studied by quantitative RT-PCR in 45 M0 prostate carcinomas and 13 benign prostate tissues.
RESULTS: Significantly reduced expression was observed for two protein phosphatase subunit genes (PPP2CB, PPP3CC) and two TRAIL decoy receptors (TNFRSF10C/DcR1, TNFRSF10D/DcR2), but not for the three established candidates nor for TRAIL death receptor genes. Low expression of PPP3CC and TNFRSF10C located at 8p21.3 was highly significantly associated with tumor recurrence. In addition to allele loss, down-regulation of TNFRSF10C and TNFRSF10D was found to be associated with hypermethylation, although bisulfite sequencing usually revealed it to be partial.
CONCLUSION: Our data strongly support a recent proposal that a segment at 8p21.3 contains crucial prostate cancer tumor suppressors. In addition, they raise the paradoxical issue of why TRAIL decoy receptors rather than death receptors are down-regulated in aggressive prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460741

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  22 in total

Review 1.  Promoter hypermethylation in prostate cancer.

Authors:  Jong Y Park
Journal:  Cancer Control       Date:  2010-10       Impact factor: 3.302

2.  Proteomic Maps of Human Gastrointestinal Stromal Tumor Subgroups.

Authors:  Yu Liu; Zhigui Li; Zhiqiang Xu; Xiuxiu Jin; Yanqiu Gong; Xuyang Xia; Yuqin Yao; Zhaofen Xu; Yong Zhou; Heng Xu; Shuangqing Li; Yong Peng; Xiaoting Wu; Lunzhi Dai
Journal:  Mol Cell Proteomics       Date:  2019-02-25       Impact factor: 5.911

3.  A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.

Authors:  Ji-Hak Jeong; Sun-Jin Park; Shohreh Iravani Dickinson; Jun-Li Luo
Journal:  Mol Cell       Date:  2016-12-29       Impact factor: 17.970

4.  ID4 is frequently downregulated and partially hypermethylated in prostate cancer.

Authors:  Anna Vinarskaja; Wolfgang Goering; Marc Ingenwerth; Wolfgang A Schulz
Journal:  World J Urol       Date:  2011-09-01       Impact factor: 4.226

5.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

6.  Genetic Variations in the 3'-untranslated Regions of Genes Involved in the Cell Cycle and Apoptosis Pathways Affect Bladder Cancer Risk.

Authors:  Qiang Zhang; Wenying Wang; Weidong Xu; Mulong Du`; Gaoxiang Ma; Hanting Liu; Haiyan Chu; N A Tong; Meilin Wang; Jianfeng Shao; Zhengdong Zhang; Lin Yuan; Jing Qian
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

7.  Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.

Authors:  Rolando A R Villacis; Tatiane R Basso; Luisa M Canto; Maísa Pinheiro; Karina M Santiago; Juliana Giacomazzi; Cláudia A A de Paula; Dirce M Carraro; Patrícia Ashton-Prolla; Maria I Achatz; Silvia R Rogatto
Journal:  J Mol Med (Berl)       Date:  2017-01-16       Impact factor: 4.599

Review 8.  Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.

Authors:  H Wang; L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

9.  Deregulation of an imprinted gene network in prostate cancer.

Authors:  Teodora Ribarska; Wolfgang Goering; Johanna Droop; Klaus-Marius Bastian; Marc Ingenwerth; Wolfgang A Schulz
Journal:  Epigenetics       Date:  2014-02-10       Impact factor: 4.528

10.  Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.

Authors:  Yu Cheng; Jin Woo Kim; Wennuan Liu; Thomas A Dunn; Jun Luo; Matthew J Loza; Seong-Tae Kim; Siqun Lilly Zheng; Jianfeng Xu; William B Isaacs; Bao-Li Chang
Journal:  Prostate       Date:  2009-02-15       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.